Asunaprevir/Daclatasvir National Patient Consultation Webinar
Published on Mar 9, 2015
Now under review by the Common Drug Review (CDR), these two separate treatments for chronic hepatitis C are presently in the patient-input stage of the review process.
No comments:
Post a Comment